Literature DB >> 30629219

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Treatment Options for Adults With Multiple Metastatic Brain Tumors.

Mario Ammirati1,2, Brian V Nahed3, David Andrews4, Clark C Chen5, Jeffrey J Olson6.   

Abstract

TARGET POPULATION: These recommendations apply to adult patients newly diagnosed with multiple (more than 1) brain metastases. QUESTION 1: In what circumstances should whole brain radiation therapy be recommended to improve tumor control and survival in patients with multiple brain metastases? RECOMMENDATION: Level 2: It is recommended that whole brain radiation therapy can be added to stereotactic radiosurgery to improve local and distant control keeping in mind the potential for worsened neurocognitive outcomes and that there is unlikely to be a significant impact on overall survival. QUESTION 2: In what circumstances should stereotactic radiosurgery be recommended to improve tumor control and survival in patients with multiple brain metastases? RECOMMENDATIONS: Level 1: In patients with 2 to 3 brain metastases not amenable to surgery, the addition of stereotactic radiosurgery to whole brain radiation therapy is not recommended to improve survival beyond that obtained with whole brain radiation therapy alone. Level 3: The use of stereotactic radiosurgery alone is recommended to improve median overall survival for patients with more than 4 metastases having a cumulative volume < 7 cc. QUESTION 3: In what circumstances should surgery be recommended to improve tumor control and survival in patients with multiple brain metastases? RECOMMENDATION: Level 3: In patients with multiple brain metastases, tumor resection is recommended in patients with lesions inducing symptoms from mass effect that can be reached without inducing new neurological deficit and who have control of their cancer outside the nervous system.The full guideline can be found at https://www.cns.org/guidelines/guidelines-treatment-adults-metastatic-brain-tumors/chapter_6.
Copyright © 2019 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Brain metastases; Cerebral metastases; Multiple metastases; Radiotherapy; Resection; Whole brain radiotherapy

Year:  2019        PMID: 30629219     DOI: 10.1093/neuros/nyy548

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

Review 1.  Guidelines in the management of CNS tumors.

Authors:  Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines.

Authors:  Susan M Chang; Hans Messersmith; Manmeet Ahluwalia; David Andrews; Priscilla K Brastianos; Laurie E Gaspar; Na Tosha N Gatson; Justin T Jordan; Mustafa Khasraw; Andrew B Lassman; Julia Maues; Maciej Mrugala; Jeffrey Raizer; David Schiff; Glen Stevens; Ashley Sumrall; Martin Van den Bent; Michael A Vogelbaum
Journal:  Neuro Oncol       Date:  2019-03-18       Impact factor: 12.300

3.  Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines.

Authors:  Susan M Chang; Hans Messersmith; Manmeet Ahluwalia; David Andrews; Priscilla K Brastianos; Laurie E Gaspar; Na Tosha N Gatson; Justin T Jordan; Mustafa Khasraw; Andrew B Lassman; Julia Maues; Maciej Mrugala; Jeffrey Raizer; David Schiff; Glen Stevens; Ashley Sumrall; Martin van den Bent; Michael A Vogelbaum
Journal:  J Clin Oncol       Date:  2019-03-18       Impact factor: 44.544

4.  Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery.

Authors:  Carmine Antonio Donofrio; Andrea Cavalli; Marco Gemma; Lucia Riccio; Alessandra Donofrio; Pietro Panni; Camillo Ferrari da Passano; Antonella Del Vecchio; Angelo Bolognesi; Riccardo Soffietti; Pietro Mortini
Journal:  Clin Exp Metastasis       Date:  2020-05-19       Impact factor: 5.150

5.  Surgery for brain metastases: radiooncology scores predict survival-score index for radiosurgery, graded prognostic assessment, recursive partitioning analysis.

Authors:  Christina Wolfert; Veit Rohde; Abdelhalim Hussein; Ingo Fiss; Silvia Hernández-Durán; Dörthe Malzahn; Annalen Bleckmann; Dorothee Mielke; Bawarjan Schatlo
Journal:  Acta Neurochir (Wien)       Date:  2022-09-24       Impact factor: 2.816

6.  Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis.

Authors:  Desmond A Brown; Victor M Lu; Benjamin T Himes; Terry C Burns; Alfredo Quiñones-Hinojosa; Kaisorn L Chaichana; Ian F Parney
Journal:  Clin Exp Metastasis       Date:  2020-01-16       Impact factor: 5.150

7.  Executive summary from American Radium Society's appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases.

Authors:  Michael T Milano; Veronica L S Chiang; Scott G Soltys; Tony J C Wang; Simon S Lo; Alexandria Brackett; Seema Nagpal; Samuel Chao; Amit K Garg; Siavash Jabbari; Lia M Halasz; Melanie Hayden Gephart; Jonathan P S Knisely; Arjun Sahgal; Eric L Chang
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

8.  Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases.

Authors:  Matthew Ramotar; Sierra Barnes; Fabio Moraes; Archya Dasgupta; Normand Laperriere; Barbara-Ann Millar; Alejandro Berlin; Tatiana Conrad; Monique van Prooijen; Andrei Damyanovich; Robert Heaton; Young-Bin Cho; Catherine Coolens; Geoffrey Liu; Frances A Shepherd; Penelope Bradbury; Natasha Leighl; Mark Bernstein; Gelareh Zadeh; Paul Kongkham; Mark Doherty; David B Shultz
Journal:  Adv Radiat Oncol       Date:  2019-11-26

9.  The Debatable Benefit of Gross-Total Resection of Brain Metastases in a Comprehensive Treatment Setting.

Authors:  Stephanie T Jünger; Lenhard Pennig; Petra Schödel; Roland Goldbrunner; Lea Friker; Martin Kocher; Martin Proescholdt; Stefan Grau
Journal:  Cancers (Basel)       Date:  2021-03-21       Impact factor: 6.639

Review 10.  Neurosurgery for brain metastasis from breast cancer.

Authors:  Yusuke Tomita; Kazuhiko Kurozumi; Kentaro Fujii; Yosuke Shimazu; Isao Date
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.